Skip to main content
Have a personal or library account? Click to login
Exploring the Causal Link Between Autoimmune Diseases and Pulmonary Arterial Hypertension: A Bidirectional Mendelian Randomization Study Cover

Exploring the Causal Link Between Autoimmune Diseases and Pulmonary Arterial Hypertension: A Bidirectional Mendelian Randomization Study

Open Access
|Jul 2025

Figures & Tables

Figure 1

Overview of the study design in this bidirectional MR study.

Table 1

Data sources and instrumental variables strength assessment.

TRAITSPHENOTYPIC CODESAMPLE SIZE (CASES/CONTROLS)ANCESTRYR2(%) (TOTAL)F (TOTAL)
Exposures
RAebi-a-GCST00231814,361/42,923European0.11066365
IBDfinn-b-K11_IBD_STRICT3,753/210,300European0.00791690
MSieu-b-1847,429/68,374European0.06006978
SLEebi-a-GCST0031565,201/9,066European0.35235081
T1Debi-a-GCST0106819,266/15,574European0.29697486
Outcomes
PAHfinn-b-I9_HYPTENSPUL125/162,837European

[i] F = R2(N-K-1)/[K(1-R2)], R2 = 2 × (1-EAF) × EAF×(b/SD)2, SD = SE × N1/2, where EAF is the effect allele frequency, b is the estimated effect on adipokines, N is the sample size of the GWAS and SE is the standard error of the estimated effect.

Table 2

Mendelian randomization estimates of RA, IBD, MS, SLE and T1D on the risk for PAH.

EXPOSURESMETHODSSNPs (n)OR95%CIp-VALUE
RAMR Egger1091.310.84–2.060.236
Weighted median1091.020.71–1.490.897
IVW1091.271.01–1.610.042
Simple mode1090.920.37–2.310.864
Weighted mode1091.090.70–1.700.702
IBDMR Egger561.170.64–2.140.607
Weighted median561.140.79–1.660.484
IVW561.291.01–1.640.043
Simple mode561.110.52–2.390.789
Weighted mode561.050.56–1.970.878
MSMR Egger1381.180.88–1.580.278
Weighted median1381.070.77–1.500.675
IVW1380.990.83–1.180.876
Simple mode1381.110.57–2.170.751
Weighted mode1381.090.78–1.520.597
SLEMR Egger920.930.71–1.220.601
Weighted median920.860.70–1.050.145
IVW921.040.91–1.190.564
Simple mode920.780.54–1.130.193
Weighted mode920.840.66–1.070.164
T1DMR Egger1751.070.92–1.230.380
Weighted median1750.980.83–1.150.786
IVW1751.101.00–1.210.061
Simple mode1751.110.76–1.600.594
Weighted mode1750.990.85–1.150.929
Table 3

Pleiotropy and heterogeneity test of the RA, IBD, MS, SLE and T1D IVs from PAH GWAS.

OUTCOMESEXPOSUREPLEIOTROPY TESTHETEROGENEITY TEST
MR-EGGERMR-EGGERINVERSE-VARIANCE WEIGHTED
INTERCEPTSEPQQ-dfQ-pvalQQ-dfQ-pval
PAH
RA–0.00450.02890.876118.15641070.217118.18351080.237
IBD0.01710.05200.74342.9250540.86143.0334550.879
MS–0.03260.02220.144145.03181360.282147.33301370.258
SLE0.03460.03630.344101.7267900.187102.7517910.188
T1D0.01180.02200.592154.77721730.837155.06491740.846
Table 4

Mendelian randomization results for effect of genetic liability to PAH on RA, IBD, MS, SLE and T1D.

OUTCOMESMETHODSSNPs (n)OR95%CIp-VALUE
RAMR Egger91.010.97–1.060.627
Weighted median91.010.98–1.030.678
IVW91.010.99–1.030.310
Simple mode91.000.97–1.030.921
Weighted mode91.000.99–1.030.805
IBDMR Egger121.061.00–1.130.066
Weighted median120.990.96–1.020.665
IVW120.990.97–1.020.513
Simple mode121.000.95–1.050.996
Weighted mode121.000.96–1.050.989
MSMR Egger71.020.96–1.080.497
Weighted median70.990.97–1.020.669
IVW70.990.97–1.020.621
Simple mode70.980.94–1.030.549
Weighted mode70.980.94–1.030.537
SLEMR Egger90.960.89–1.040.347
Weighted median91.030.99–1.070.180
IVW91.010.97–1.050.542
Simple mode91.030.95–1.110.523
Weighted mode91.030.98–1.080.252
T1DMR Egger121.020.96–1.080.591
Weighted median121.000.97–1.030.951
IVW121.010.99–1.040.262
Simple mode121.000.95–1.060.994
Weighted mode121.000.95–1.050.892
DOI: https://doi.org/10.5334/gh.1445 | Journal eISSN: 2211-8179
Language: English
Submitted on: Aug 11, 2024
Accepted on: Jun 17, 2025
Published on: Jul 4, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Chao Ma, Cheng Gong, Bin Wang, Yangmeina Li, Yongxiang Qian, Xiaoying Zhang, Dongmei Di, Min Wang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.